* IRIDEX Corp IRIX.OQ IRIX.O is expected to show a rise
in
quarterly revenue when it reports results on May 12.
* The Mountain View California-based company is expected to
report a 12.2% increase in revenue to $13.415 million from
$11.96 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for IRIDEX Corp is for
a loss
of 16 cents per share. For the same quarter last year, the
company reported a loss of 14 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for IRIDEX Corp
is
$9.75, above its last closing price of $3.36.
This summary was machine generated May 10 at 20:49 GMT. All
figures in US dollars unless otherwise stated